您当前的位置：
首页 >
文章列表页 >
A double-blind randomised controlled clinical trial of Shenling Baizhu Granules in treating low anterior resection syndrome in rectal cancer
Clinical Studies | 更新时间：2024-08-02

    • A double-blind randomised controlled clinical trial of Shenling Baizhu Granules in treating low anterior resection syndrome in rectal cancer

    • “Clinical trials conducted by the Department of Gastroenterology and the Department of Integrated Traditional Chinese and Western Medicine at Peking University First Hospital have shown that Shenling Baizhu Granules can effectively improve LARS symptoms and enhance the quality of life of patients after low anterior resection of rectal cancer.”
    • Journal of Beijing University of Traditional Chinese Medicine   Vol. 47, Issue 7, Pages: 953-960(2024)

    • DOI：10.3969/j.issn.1006-2157.2024.07.011    

      CLC： R285.6

    • Received：20 February 2024，

      Published Online：12 June 2024，

      Published：30 July 2024

    移动端阅览

  • FENG Shuo, YE Hui, WU Yingchao, et al. A double-blind randomised controlled clinical trial of Shenling Baizhu Granules in treating low anterior resection syndrome in rectal cancer[J]. Journal of beijing university of traditional chinese medicine, 2024, 47(7): 953-960. DOI： 10.3969/j.issn.1006-2157.2024.07.011.

  •  
  •  

0

Views

494

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0